Yango Awards Drivers

 Yango has recognized and awarded a total of 250 best rated drivers with fuel cards and other gifts as part of the celebration to commemorate the International Taxi Driver Day. The first top 20 recipients were issued fuel cards worth ZMW 1,000 each while the rest will receive ZMW 400 each as the awarding program […]

Lorlatinib found to be safe and effective for patients with ALK-driven relapsed/refractory high-risk neuroblastoma

In a significant step for the treatment of neuroblastoma, an international group of researchers led by Children’s Hospital of Philadelphia (CHOP), Winship Cancer Institute of Emory University and the New Approaches to Neuroblastoma Therapy (NANT) Consortium has shown that the targeted therapy lorlatinib is safe and effective in treating high-risk neuroblastoma.

Nasal vaccine to prevent COVID-19 passes first tests

Coronaviruses spread primarily through the air. When infected people speak, cough, sneeze or laugh, they expel droplets of saliva containing the virus. Other people then breathe in these airborne pathogens and become infected themselves. A research team in Berlin decided to try to fight the virus that causes COVID-19 where it first takes hold: the mucous membranes of the nose, mouth, throat, and lungs.

How broccoli sprouts became an emerging tool against a range of diseases

Strolling through the produce section of your local grocery story, you might notice—tucked between the pre-sliced radishes and the plastic-wrapped mushrooms—a container of broccoli sprouts, a mat of wispy white shoots with spring-green leaves the shape of a handmade valentine. Perhaps you took that container home and discovered the sprouts to be earthy on the tongue, less nutty than their more popular cousin alfalfa. Not pepper-spicy but horseradish-spicy, a heat that tickles the back of the nose. Perhaps you found that just a handful added complexity, a satisfying crunch, to sandwiches and salads.

ZAMBIA PRAISED FOR MALARIA FIGHT

AFRICAN Leaders Malaria Alliance has said Zambia is a leader and example of how Malaria prevention and elimination programmes should be run on the Continent.

African Leaders Malaria Alliance Executive Secretary Joy Phumaphi was speaking when she paid a courtesy call on Health Minister Sylvia Masebo at her Office in Lusaka yesterday.

Ms Phumaphi who is also former Minister of Health in Botswana said Zambia is a leader and example of how Malaria prevention and elimination programmes should be run on the Continent.

She said the Alliance has a lot of confidence that Zambia will be able to stir a cross border Malaria programme to ensure that the disease is eliminated not just in Zambia but the Continent.

And Ms Phumaphi said the alliance will support Zambia in finding partners that will assist in the manufacturing of new insecticide mosquito nets.

Meanwhile  Ms. Masebo said government is committed to provide quality health care services and evidence based Malaria inventions as close to the family as possible.

Ms Masebo said as the Ministry advances equity it will prioritize access to services in the hard to reach and rural communities mostly affected by Malaria.

The African Leaders Malaria Alliance is an alliance of all heads of States and government on the Continent. – ZNBC

Technology-driven treatment found to be as effective for social anxiety as psychiatric medications like Cipralex

A new clinical trial conducted at Tel Aviv University has demonstrated an effective technology-driven alternative to psychiatric medications for people with social anxiety. The groundbreaking study found that GC-MART (Gaze-Contingent Music Reward Therapy) is as effective in treating social anxiety disorder as drugs from the SSRI family. The study found that the innovative treatment, developed at TAU, relieved the symptoms of about 50% of the participating patients. The researchers hope that this therapy will soon be available as an effective alternative to psychiatric medications.

How two different types of immune cells help two billion people keep tuberculosis in check

More than 10 million people are sickened by tuberculosis (TB) globally each year, resulting in 1.5 million deaths. Yet, as many as two billion people are infected with Mycobaterium tuberculosis, the bacterium that causes tuberculosis, and are otherwise healthy and asymptomatic. Scientists who study TB look at those individuals who can tolerate and contain the infection in hopes of developing better treatments and vaccines.